Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/43318| metadata.artigo.dc.title: | SARS-CoV-2 and the cardiovascular system |
| metadata.artigo.dc.creator: | Hafiane, Anouar |
| metadata.artigo.dc.subject: | COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Myocardial injury Angiotensin-converting enzyme 2 (ACE2) Severe acute respiratory syndrome Troponin |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | Nov-2020 |
| metadata.artigo.dc.identifier.citation: | HAFIANE, A. SARS-CoV-2 and the cardiovascular system. Clinica Chimica Acta, [S.l.], v. 510, p. 311-316, Nov. 2020. |
| metadata.artigo.dc.description.abstract: | The coronavirus disease COVID-19 is a public health emergency caused by a novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection uses the angiotensin-converting enzyme 2 (ACE2) receptor, and typically spreads through the respiratory tract. Invading viruses can elicit an exaggerated host immune response, frequently leading to a cytokine storm that may be fueling some COVID-19 death. This response contributes to multi-organ dysfunction. Accumulating data points to an increased cardiovascular disease morbidity, and mortality in COVID-19 patients. This brief review explores potential available evidence regarding the association between COVID-19, and cardiovascular complications. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S0009898120303430 http://repositorio.ufla.br/jspui/handle/1/43318 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.